Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3300 USD | 0.00% |
|
+8.20% | -51.48% |
| Market Cap | 1.09M 954K 880K 814K 1.54M 104M 1.57M 10.58M 4.11M 50.95M 4.08M 3.99M 177M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.77M -1.55M -1.43M -1.32M -2.51M -169M -2.56M -17.21M -6.69M -82.83M -6.64M -6.49M -288M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +8.20% | ||
| Current month | +17.86% | ||
| 1 month | +6.45% | ||
| 3 months | -26.67% | ||
| 6 months | -56.00% | ||
| Current year | -51.48% |
| 1 week | 0.25 | 0.39 | |
| 1 month | 0.25 | 0.39 | |
| Current year | 0.15 | 0.79 | |
| 1 year | 0.15 | 0.97 | |
| 3 years | 0.15 | 93.75 | |
| 5 years | 0.15 | 2,767.51 | |
| 10 years | 0.15 | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-01 | Free | Company | 111,209 | 3.4934% | ||
| 25-03-30 | Free | Company | 33,724 | 1.6419% | ||
| 24-12-30 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +8.20% | +41.45% | -99.61% | 1.09M | ||
| -1.53% | +0.78% | +72.33% | +127.47% | 57.72B | ||
| -2.45% | -7.32% | +65.23% | +83.15% | 52.65B | ||
| +3.35% | +8.50% | +20.76% | +469.12% | 24.46B | ||
| -0.84% | -1.21% | -16.90% | -13.63% | 23.84B | ||
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | ||
| -0.24% | +5.11% | +38.76% | -25.95% | 17.8B | ||
| +2.34% | +14.18% | +220.96% | +380.99% | 17.29B | ||
| -6.73% | +9.90% | +36.04% | - | 15.28B | ||
| -2.08% | +3.47% | +28.32% | +192.76% | 14.35B | ||
| Average | -1.12% | +4.68% | +54.93% | +123.18% | 24.27B | |
| Weighted average by Cap. | -1.28% | +2.71% | +57.68% | +139.25% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.23 1.14 1.05 1.99 134.44 2.03 13.67 5.31 65.79 5.27 5.16 228.38 |
| Net income | -11.65M -10.22M -9.44M -8.72M -16.53M -1.12B -16.86M -113M -44.07M -546M -43.76M -42.8M -1.9B | -2.91M -2.55M -2.36M -2.18M -4.13M -279M -4.21M -28.32M -11M -136M -10.92M -10.68M -473M |
| Net Debt | -2.59M -2.28M -2.1M -1.94M -3.68M -248M -3.75M -25.25M -9.81M -122M -9.74M -9.53M -422M | -2.86M -2.5M -2.31M -2.14M -4.05M -273M -4.13M -27.79M -10.8M -134M -10.72M -10.49M -464M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | US$0.3300 | 0.00% | 913 |
| 26-07-06 | US$0.3300 | +8.20% | 3,181 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
















